Skip to main content

Peer Review reports

From: Efficacy and safety of mirogabalin for chemotherapy-induced peripheral neuropathy: a prospective single-arm trial (MiroCIP study)

Original Submission
31 Mar 2023 Submitted Original manuscript
17 May 2023 Reviewed Reviewer Report
23 May 2023 Reviewed Reviewer Report
1 Jun 2023 Reviewed Reviewer Report
14 Jul 2023 Author responded Author comments - Sonoko Misawa
Resubmission - Version 2
14 Jul 2023 Submitted Manuscript version 2
28 Jul 2023 Author responded Author comments - Sonoko Misawa
Resubmission - Version 3
28 Jul 2023 Submitted Manuscript version 3
31 Jul 2023 Author responded Author comments - Sonoko Misawa
Resubmission - Version 4
31 Jul 2023 Submitted Manuscript version 4
11 Aug 2023 Reviewed Reviewer Report
17 Aug 2023 Reviewed Reviewer Report
21 Aug 2023 Reviewed Reviewer Report
12 Oct 2023 Author responded Author comments - Sonoko Misawa
Resubmission - Version 5
12 Oct 2023 Submitted Manuscript version 5
22 Oct 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
23 Oct 2023 Editorially accepted
11 Nov 2023 Article published 10.1186/s12885-023-11560-4

You can find further information about peer review here.

Back to article page